Mindray Medical International Limited
Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China. Founded in 1991, the company has established a strong presence in over 190 countries, focusing on key operational regions such as North America, Europe, and Asia. Specialising in the development of innovative medical technologies, Mindray's core business areas include patient monitoring and life support, in-vitro diagnostics, and medical imaging. The company is renowned for its high-quality products, such as advanced ultrasound systems and versatile anaesthesia machines, which are distinguished by their reliability and user-friendly design. With a commitment to enhancing healthcare delivery, Mindray has achieved significant milestones, including numerous industry awards and recognitions. As a prominent player in the medical device industry, Mindray continues to drive advancements that improve patient outcomes and streamline clinical workflows.
DitchCarbon Score
How does Mindray Medical International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mindray Medical International Limited's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mindray Medical International Limited's reported carbon emissions
In 2021, Mindray Medical International Limited reported total carbon emissions of approximately 55,765,320 kg CO2e, comprising 2,432,960 kg CO2e from Scope 1 and 53,332,360 kg CO2e from Scope 2 emissions. This data highlights the company's significant carbon footprint, primarily driven by its operational activities. In terms of reduction initiatives, Mindray achieved an 8.51% decrease in carbon emission intensity from 2022 to 2023, specifically targeting Scope 2 emissions. This commitment reflects the company's ongoing efforts to enhance its sustainability practices and reduce its environmental impact. Mindray has not disclosed any Scope 3 emissions data, indicating a potential area for future focus. The company does not currently participate in the Science Based Targets initiative (SBTi) or other formal climate pledges, but its recent reduction in carbon intensity demonstrates a proactive approach to climate commitments. Overall, Mindray Medical International Limited's emissions data and reduction initiatives underscore its commitment to addressing climate change while operating within the medical technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | - | - | 0,000,000 |
| Scope 2 | - | - | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mindray Medical International Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
